Adam Bingaman, MD, PhD, MBA

Dr. Bingaman graduated from Cornell University with a Bachelor of Arts in biochemistry, received his medical degree from Boston University School of Medicine, and then went on to complete his general surgery residency training at Emory University in Atlanta, Georgia. During his residency, he earned a doctorate in immunology from Emory University Graduate School of Biological Sciences, where his research focused on how the immune system rejects transplanted tissues. He then went on to complete his fellowship training in kidney and pancreas transplantation surgery at the University of Maryland.

Dr. Bingaman is board-certified by the American Board of Surgery, is a member of the American College of Surgeons, and has published extensively in the field of transplantation immunology.

As Chief Medical Officer for a large tertiary care statutory teaching hospital, his focus is to drive strategic value-based growth with responsible resource utilization, while driving provider and patient experience.

As the former director of the abdominal transplant program at Methodist Hospital | Specialty and Transplant in San Antonio, Texas, he built the largest living donor, paired donor, and Hispanic kidney transplant programs in the United States and set national records for increased access to care over more than ten years.

As the National Medical Director for HCA solid organ transplant programs, he has responsibility with all HCA kidney, liver, heart, and lung transplant programs to stimulate programmatic excellence, innovation, and quality of care.